229 related articles for article (PubMed ID: 26207978)
1. Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies.
Siepel FJ; Dalen I; Grüner R; Booij J; Brønnick KS; Buter TC; Aarsland D
Mov Disord; 2016 Jan; 31(1):118-25. PubMed ID: 26207978
[TBL] [Abstract][Full Text] [Related]
2. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P
Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
4. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An
van der Zande JJ; Joling M; Happach IG; Vriend C; Scheltens P; Booij J; Lemstra AW
Neuroimage Clin; 2020; 25():102062. PubMed ID: 31790878
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction.
David R; Koulibaly M; Benoit M; Garcia R; Caci H; Darcourt J; Robert P
Clin Neurol Neurosurg; 2008 Jan; 110(1):19-24. PubMed ID: 17900799
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
Taylor JP; Colloby SJ; McKeith IG; Burn DJ; Williams D; Patterson J; O'Brien JT
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1069-71. PubMed ID: 17299017
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
Tang Z; Hirano S; Koizumi Y; Izumi M; Kitayama Y; Yamagishi K; Tamura M; Ishikawa A; Kashiwado K; Iimori T; Mukai H; Yokota H; Horikoshi T; Uno T; Kuwabara S
J Alzheimers Dis; 2024; 100(1):127-137. PubMed ID: 38848178
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
[TBL] [Abstract][Full Text] [Related]
11. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
[TBL] [Abstract][Full Text] [Related]
12. Lower
Joling M; Vriend C; van der Zande JJ; Lemstra AW; van den Heuvel OA; Booij J; Berendse HW
Neuroimage Clin; 2018; 19():130-136. PubMed ID: 30035010
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of
Maltais DD; Jordan LG; Min HK; Miyagawa T; Przybelski SA; Lesnick TG; Reichard RR; Dickson DW; Murray ME; Kantarci K; Boeve BF; Lowe VJ
J Nucl Med; 2020 Nov; 61(11):1628-1635. PubMed ID: 32198310
[TBL] [Abstract][Full Text] [Related]
14.
Kasanuki K; Iseki E; Ota K; Kondo D; Ichimiya Y; Sato K; Arai H
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):358-365. PubMed ID: 27480759
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.
Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Colloby SJ; Lloyd J; Petrides G; McKeith IG; Thomas AJ
Psychol Med; 2018 Oct; 48(14):2384-2390. PubMed ID: 29362011
[TBL] [Abstract][Full Text] [Related]
16. Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
Yoo HS; Jeong SH; Oh KT; Lee S; Sohn YH; Ye BS; Yun M; Lee PH
Brain; 2022 Dec; 145(12):4448-4458. PubMed ID: 35234856
[TBL] [Abstract][Full Text] [Related]
17. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.
van der Zande JJ; Booij J; Scheltens P; Raijmakers PG; Lemstra AW
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1060-6. PubMed ID: 26830298
[TBL] [Abstract][Full Text] [Related]
18. Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies.
Ziebell M; Andersen BB; Pinborg LH; Knudsen GM; Stokholm J; Thomsen G; Karlsborg M; Høgh P; Mørk ML; Hasselbalch SG
J Nucl Med; 2013 Jul; 54(7):1072-6. PubMed ID: 23637201
[TBL] [Abstract][Full Text] [Related]
19. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review.
Jreige M; Kurian GK; Perriraz J; Potheegadoo J; Bernasconi F; Stampacchia S; Blanke O; Alessandra G; Lejay N; Chiabotti PS; Rouaud O; Nicod Lalonde M; Schaefer N; Treglia G; Allali G; Prior JO
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1988-2035. PubMed ID: 36920494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
